RISCA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 387
AS - Asia 207
NA - Nord America 127
SA - Sud America 26
AF - Africa 3
OC - Oceania 2
Totale 752
Nazione #
IT - Italia 179
US - Stati Uniti d'America 126
SG - Singapore 122
GB - Regno Unito 62
IE - Irlanda 33
RU - Federazione Russa 33
DE - Germania 31
HK - Hong Kong 28
BR - Brasile 22
CN - Cina 20
ID - Indonesia 16
NL - Olanda 13
JP - Giappone 10
FI - Finlandia 9
FR - Francia 8
AT - Austria 5
BE - Belgio 5
IN - India 4
PH - Filippine 3
AU - Australia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
MA - Marocco 2
PL - Polonia 2
RO - Romania 2
AL - Albania 1
AR - Argentina 1
CA - Canada 1
ES - Italia 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
PK - Pakistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 752
Città #
Singapore 111
Milan 52
Coventry 36
Dublin 33
Hong Kong 26
Santa Clara 26
Jakarta 16
Frankfurt am Main 13
Shanghai 12
Florence 11
Helsinki 8
Lambeth 8
Melzo 8
New York 8
Messina 7
Munich 7
Rome 6
Yerres 6
Ashburn 5
Brussels 5
Piacenza 5
Bath 4
Berlin 4
Caronno Pertusella 4
Kyoto 4
Romola 4
Vienna 4
West Jordan 4
Bedford 3
Chicago 3
Cinisello Balsamo 3
Lainate 3
Manila 3
Naples 3
Nuremberg 3
San Jose 3
Scandicci 3
Sesto San Giovanni 3
Acquafredda 2
Aversa 2
Biandronno 2
Bloemendaal 2
Brno 2
Cambridge 2
Castelfranco Emilia 2
Cesano Maderno 2
Cluj-Napoca 2
Fort Worth 2
Grassobbio 2
Hirosaki 2
Kochi 2
Los Angeles 2
Nagasaki 2
Paris 2
Pavia 2
Seregno 2
Shenzhen 2
Slough 2
Sulmona 2
Sydney 2
Tokyo 2
Vercelli 2
Warsaw 2
Alvorada 1
Americana 1
Amman 1
Amsterdam 1
Anápolis 1
Assis 1
Atibaia 1
Belo Horizonte 1
Blumenau 1
Bonndorf 1
Bragança Paulista 1
Brugherio 1
Byron Center 1
Cape Town 1
Capão do Leão 1
Caracas 1
Casalecchio di Reno 1
Catania 1
Cernusco sul Naviglio 1
Chennai 1
Colombo 1
Cormano 1
Cotia 1
Cuenca 1
Curitiba 1
Cusano Milanino 1
Cássia 1
Dallas 1
Don Torcuato 1
Falkenstein 1
Genoa 1
Groningen 1
Indore 1
Islington 1
Itamaraju 1
Ituiutaba 1
Lappeenranta 1
Totale 554
Nome #
Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B 87
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 80
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 76
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 76
Basket trials in very rare diseases: are they feasible? 74
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 73
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 71
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 55
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 53
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 46
Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy 38
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 35
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 21
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 11
Totale 796
Categoria #
all - tutte 4.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 0 0 0 1 6 11 6
2023/2024250 7 11 5 15 19 49 36 17 17 26 23 25
2024/2025522 36 89 78 76 71 70 90 12 0 0 0 0
Totale 796